Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.
Board of Directors Board of Directors to approve the consolidated financial statements and the draft financial statements as at 31 December 2024.
28 April 2025
Members' Meeting Shareholders' Meeting for the approval of the annual financial statements as at 31 December 2024 and presentation of the consolidated financial statements, on first call, and on 29 April 2025, on second call, if any.
30 September 2025
Board of Directors Board of Directors to approve the voluntarily audited consolidated half-yearly financial report as at 30 June 2025.
Investor Relations Manager
Contact
Gabriele Salaris
Email
This email address is being protected from spambots. You need JavaScript enabled to view it.
